Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation. (2019)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12885-019-6308-7
PubMed Identifier: 31727006
Publication URI: http://europepmc.org/abstract/MED/31727006
Type: Journal Article/Review
Volume: 19
Parent Publication: BMC cancer
Issue: 1
ISSN: 1471-2407